Background: |
The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. |
Applications: |
ELISA, IHC |
Name of antibody: |
VLDLR |
Immunogen: |
Synthetic peptide of humanVLDLR |
Full name: |
very low density lipoprotein receptor |
Synonyms: |
CARMQ1; CHRMQ1; VLDLRCH |
SwissProt: |
P98155 |
ELISA Recommended dilution: |
2000-5000 |
IHC positive control: |
Human liver cancer and Human thyroid cancer |
IHC Recommend dilution: |
25-100 |